As we approach the end of the year, ANS Biotech is thrilled to announce an exclusive 15% discount on all preclinical pain studies signed before November 30, 2024.
This limited-time offer is our way of showing appreciation for your continued partnership and supporting your research endeavors as we transition into the new year.
Why Choose ANS Biotech?
✅Specialized expertise: We are a Contract Research Organization dedicated to in vivo pharmacology of pain, providing tailored solutions for your unique research needs.
✅Comprehensive services: Our ALGOGram™2.0 screening platform offers a dual focus on efficacy and safety.
An invaluable advantage to understand both the therapeutic effects and potential adverse impacts of compounds in early-stage drug development.
✅Unrivalled lead times: We pride ourselves on our efficiency, guaranteeing a maximum of three weeks between the technical proposal and the start of the experimental phase. This ensures that you can meet your research goals without unnecessary delays.
How to redeem your discount?
At ANS Biotech, we understand the critical importance of your R&D efforts in the field of Pain.
To support your progress, we are pleased to offer a special 15% for all the studies signed from now to 30NOV2024.
Thank you for choosing ANS Biotech as your trusted partner in preclinical pain pharmacology!
👉 Interested in learning more?
Contact us today!
Stay ahead in pain research with ANS Biotech!